Page 45 - 《中国药房》2023年19期
P. 45

[18]
          转录 。本研究证实清热化湿方能够上调 miRNA-155                            volvement  of  TGF- β/SMAD-2  signal  mediated  by  miR-
          表达,抑制 Wnt/β-catenin 信号通路中 Wnt7、β-catenin 和              155  in  gastric  cancer  and  the  intervention  of  Qingre
          TCF-4的表达,从而抑制胃癌细胞的生长,进一步阐明了                             huashi formula[J]. Lishizhen Med Mater Med Res,2021,
          清热化湿方防治胃癌的效用机制。                                         32(11):2613-2618.
                                                             [ 9 ]  黄晓婉,孙健,张珏,等. miR-186-5p靶向CXCL13基因通
              综上所述,清热化湿方可通过上调 miRNA-155,抑
                                                                  过Wnt/β-catenin信号调节胃癌HGC-27细胞增殖、凋亡、
          制Wnt/β-catenin信号通路,进而抑制胃癌荷瘤模型裸鼠                         细胞周期、迁移和侵袭[J]. 肿瘤药学,2023,13(3):290-296.
          瘤体生长。但本研究只对miRNA-155进行过表达处理,
                                                                  HUANG  X  W,SUN  J,ZHANG  Y,et  al.  miR-186-5p
          未进行沉默,后续笔者将从正反两方面研究清热化湿方
                                                                  targets  CXCL13  gene  and  regulates  the  proliferation,
          和miRNA-155之间的关系,积极阐明清热化湿方治疗胃                            apoptosis,  cell  cycle,migration  and  invasion  of  gastric
          癌的作用机制,为清热化湿方在临床中的应用提供更                                 cancer HGC-27 cell through Wnt/β-catenin signaling[J].
          多、更可靠的循证依据。                                             Anti Tumor Pharm,2023,13(3):290-296.
          参考文献                                               [10]  陈奇. 中药药理研究方法学[M]. 3版.北京:人民卫生出
          [ 1 ]  SMYTH  E  C,NILSSON  M,GRABSCH  H  I,et  al.  Ga-   版社,2011:121.
              stric cancer[J]. Lancet,2020,396(10251):635-648.    CHEN Q. Pharmacological research methodology of tradi‐
          [ 2 ]  WANG F H,ZHANG X T,LI Y F,et al. The Chinese So‐  tional Chinese medicine[M]. 3rd edition. Beijing:People’s
              ciety  of  Clinical  Oncology (CSCO):clinical  guidelines   Health Publishing House,2011:121.
              for the diagnosis and treatment of gastric cancer,2021[J].   [11]  张保静,陈远能,张涛 . 基于 CD14,IL-1β 表达及 SGC-
              Cancer Commun,2021,41(8):747-795.                   7901细胞凋亡变化探讨清热化湿方防治胃癌的机制[J].
          [ 3 ]  SEENEEVASSEN L,BESSÈDE E,MÉGRAUD F,et al.        中国实验方剂学杂志,2013,19(20):246-250.
              Gastric  cancer:advances  in  carcinogenesis  research  and   ZHANG  B  J,CHEN Y  N,ZHANG  T.  Effect  of  Qingre
              new therapeutic strategies[J]. Int J Mol Sci,2021,22(7):  Huashi  dectction  on  regulating  SGC-7901  cell  apoptosis
              3418.                                               by mediating CD-14 and IL-1β for prevention and treat‐
          [ 4 ]  黄李冰雪,张涛,钟婵,等. 基于网络药理学的清热化湿                       ment of colon cancer[J].Chin J Exp Tradit Med Formulae,
              方治疗胃癌的药理机制研究[J]. 中药材,2019,42(10):                   2013,19(20):246-250.
              2375-2384.                                     [12]  LU T  X,ROTHENBERG  M  E.  microRNA[J].  J Allergy
              HUANG L B X,ZHANG T,ZHONG C,et al. Pharmaco‐        Clin Immunol,2018,141(4):1202-1207.
              logical  mechanism  of  Qingre  huashi  decoction  in  treat‐  [13]  BERSIMBAEV  R,PULLIERO  A,BULGAKOVA  O,et
              ment of gastric cancer based on network pharmacology[J].   al. Radon biomonitoring and microRNA in lung cancer[J].
              J Chin Med Mater,2019,42(10):2375-2384.             Int J Mol Sci,2020,21(6):2154.
          [ 5 ]  黄李冰雪,张涛,钟婵,等 . 清热化湿方对 MNU 联合幽               [14]  LI H L,XIE S P,LIU M,et al. The clinical significance of
              门螺杆菌感染相关胃癌细胞中 CD14、NF-κB 及 IL-6 表                   downregulation  of  miR-124-3p,miR-146a-5p,miR-155-
              达的影响[J]. 时珍国医国药,2019,30(5):1053-1057.               5p and miR-335-5p in gastric cancer tumorigenesis[J]. Int
              HUANG L B X,ZHANG T,ZHONG C,et al. The effect       J Oncol,2014,45(1):197-208.
              of  Qingre  huashi  decoction  on  the  expression  of  CD14,  [15]  NUSSE R,CLEVERS H. Wnt/β-catenin signaling,disease,
              NF- κB  and  IL-6  in  gastric  cancer  cells  associated  with   and  emerging  therapeutic  modalities[J].  Cell,2017,169
              MNU  combined  with  Helicobacter  pylori  infection[J].  (6):985-999.
              Lishizhen Med Mater Res,2019,30(5):1053-1057.  [16]  YU Z Y,JIANG X Y,QIN L,et al. A novel UBE2T in‐
          [ 6 ]  钟婵,张涛,黄李冰雪,等 . 清热化湿方对 MNU 联合幽                    hibitor suppresses Wnt/β-catenin signaling hyperactiva‐
              门螺杆菌感染小鼠胃组织中TNF-α、IL-8及TLR-4水平                      tion  and  gastric  cancer  progression  by  blocking  RACK1
              的影响[J]. 中成药,2020,42(5):1339-1343.                   ubiquitination[J]. Oncogene,2021,40(5):1027-1042.
              ZHONG C,ZHANG T,HUANG L B X,et al. The effect   [17]  刘博,赵建国,夏爱辉,等 . Wnt7a 蛋白在胃癌组织中的
              of Qingre huashi decoction on the levels of TNF-α,IL-8   表达及其与预后的关系[J]. 中国普通外科杂志,2019,28
              and TLR-4  in  gastric  tissue  of  mice  infected  with  MNU   (4):449-455.
              combined  with  Helicobacter  pylori[J].  Chin  Tradit  Pat   LIU B,ZHAO J G,XIA A H,et al. Expression of Wnt7a
              Med,2020,42(5):1339-1343.                           in gastric cancer tissue and its association with prognosis
          [ 7 ]  ZHANG T,LIU  C,HUANG  S,et  al. A  downmodulated   [J].Chin J Gen Surg,2019,28(4):449-455.
              microRNA  profiling  in  patients  with  gastric  cancer[J].   [18]  ZENG  J  H,MA  X,ZHAO  Z Y,et  al.  Ginsenoside  Rb1
              Gastroenterol Res Pract,2017,2017:1526981.          lessens  gastric  precancerous  lesions  by  interfering  with
          [ 8 ]  赵俊佳,陈远能,张涛,等 . miR-155 介导 TGF-β/SMAD-            β-catenin/TCF4 interaction[J]. Front Pharmacol,2021,
              2信号参与胃癌及清热化湿方的干预研究[J]. 时珍国医                         12:682713.
              国药,2021,32(11):2613-2618.                                     (收稿日期:2023-04-01  修回日期:2023-08-15)
              ZHAO J J,CHEN Y N,ZHANG T,et al. Study on the in‐                                   (编辑:唐晓莲)


          中国药房  2023年第34卷第19期                                              China Pharmacy  2023 Vol. 34  No. 19    · 2343 ·
   40   41   42   43   44   45   46   47   48   49   50